{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T02:38:22Z","timestamp":1788489502999,"version":"build-2803163510"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T00:00:00Z","timestamp":1574380800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007219","name":"Natural Science Foundation of Shanghai","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2019.00789","type":"journal-article","created":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T04:53:13Z","timestamp":1574398393000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Granulocyte-Colony-Stimulating Factor Effectively Shortens Recovery Duration in Anti-Thyroid-Drug-Induced Agranulocytosis: A Systematic Review and Meta-Analysis"],"prefix":"10.3389","volume":"10","author":[{"given":"Yonghui","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingbing","family":"Zha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,11,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1089\/thy.2010.0417","article-title":"Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the american Thyroid association and american association of clinical endocrinologists","volume":"21","author":"Bahn","year":"2011","journal-title":"Thyroid."},{"key":"B2","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1056\/NEJMra042972","article-title":"Antithyroid drugs","volume":"352","author":"Cooper","year":"2005","journal-title":"N Engl J Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/S0140-6736(16)00278-6","article-title":"Hyperthyroidism","volume":"388","author":"De Leo","year":"2016","journal-title":"Lancet."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1089\/thy.2016.0229","article-title":"American thyroid association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis","volume":"26","author":"Ross","year":"2016","journal-title":"Thyroid."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1056\/NEJMra1413485","article-title":"Aplastic anemia","volume":"379","author":"Young","year":"2018","journal-title":"N Engl J Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"bcr0520102993","DOI":"10.1136\/bcr.05.2010.2993","article-title":"Successful treatment of methimazole-induced severe aplastic anaemia in a diabetic patient with other co-morbidities","volume":"2010","author":"Josol","year":"2010","journal-title":"BMJ Case Rep."},{"key":"B7","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1590\/0004-2730000003216","article-title":"Marrow hypoplasia: a rare complication of untreated Grave s disease","volume":"58","author":"Garcia","year":"2014","journal-title":"Arquivos Brasil Endocrinol Metabol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1001\/archinte.1990.00390150107020","article-title":"Antithyroid drug\u2013induced agranulocytosis: the usefulness of routine white blood cell count monitoring","volume":"150","author":"Tajiri","year":"1990","journal-title":"Arch Intern Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.1056\/NEJMcp0801880","article-title":"Graves' disease","volume":"358","author":"Brent","year":"2008","journal-title":"N Engl J Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/S0140-6736(11)60782-4","article-title":"Thyrotoxicosis","volume":"379","author":"Franklyn","year":"2012","journal-title":"Lancet."},{"key":"B11","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s40268-017-0172-1","article-title":"Antithyroid drug-induced agranulocytosis: state of the art on diagnosis and management","volume":"17","author":"Vicente","year":"2017","journal-title":"Drugs R D."},{"key":"B12","doi-asserted-by":"publisher","first-page":"3187","DOI":"10.1200\/JCO.2006.06.4451","article-title":"2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline","volume":"24","author":"Smith","year":"2006","journal-title":"J Clin Oncol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"131","DOI":"10.15605\/jafes.031.02.08","article-title":"The effects of GCSF on the recovery time and duration of hospitalization in patients with anti-thyroid drug-induced agranulocytosis in a tertiary hospital","volume":"31","author":"Clauna-Lumanta","year":"2016","journal-title":"J ASEAN Feder Endocr Soc."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA."},{"key":"B16","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1471-2288-5-13","article-title":"Estimating the mean and variance from the median, range, and the size of a sample","volume":"5","author":"Hozo","year":"2005","journal-title":"BMC Med Res Methodol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1089\/thy.2015.0439","article-title":"Characteristics of antithyroid drug-induced agranulocytosis in patients with hyperthyroidism: a retrospective analysis of 114 cases in a single institution in china involving 9690 patients referred for radioiodine treatment over 15 years","volume":"26","author":"Yang","year":"2016","journal-title":"Thyroid."},{"key":"B18","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1089\/thy.2005.15.292","article-title":"Antithyroid drug-induced agranulocytosis: how has granulocyte colony-stimulating factor changed therapy?","volume":"15","author":"Tajiri","year":"2005","journal-title":"Thyroid."},{"key":"B19","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1089\/thy.1999.9.29","article-title":"Granulocyte Colony-Stimulating Factor (G-CSF) does not improve recovery from antithyroid drug-induced agranulocytosis: a prospective study","volume":"9","author":"Fukata","year":"1999","journal-title":"Thyroid."},{"key":"B20","volume-title":"In-Hospital Mortality Secondary to Methimazole-Induced Agranulocytosis. Thyroid","author":"Zelada","year":"2016"},{"key":"B21","doi-asserted-by":"publisher","first-page":"E49","DOI":"10.1210\/jc.2011-2221","article-title":"Antithyroid drug-induced hematopoietic damage: a retrospective cohort study of agranulocytosis and pancytopenia involving 50,385 patients with graves' disease","volume":"97","author":"Watanabe","year":"2012","journal-title":"J Clin Endocrinol Metabol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1093\/qjmed\/94.8.423","article-title":"Haematopoietic growth factor in antithyroid-drug-induced agranulocytosis","volume":"94","author":"Andr\u00e8s","year":"2001","journal-title":"QJM."},{"key":"B23","first-page":"242","article-title":"Antithyroid drug-induced agranulocytosis: report of 13 cases","volume":"30","author":"Huang","year":"2007","journal-title":"Chang Gung Med J."},{"key":"B24","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1093\/qjmed\/92.8.455","article-title":"Antithyroid-drug-induced agranulocytosis complicated by life-threatening infections","volume":"92","author":"Sheng","year":"1999","journal-title":"QJM."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1210\/jcem.77.5.7521347","article-title":"Treatment of methimazole-induced agranulocytosis using recombinant human granulocyte colony-stimulating factor (rhG-CSF)","volume":"77","author":"Tamai","year":"1993","journal-title":"J Clin Endocrinol Metabol."},{"key":"B26","first-page":"2087","article-title":"Clinical analysis of 64 cases with propylthiour acil- induced granulocytopenia","volume":"16","author":"Feng","year":"2006","journal-title":"China J Mod Med."},{"key":"B27","first-page":"297","article-title":"The role of carnitine in intracellular metabolism","volume":"28","author":"Bremer","year":"1990","journal-title":"J Clin Chem Clin Biochem Z Klin Chem Klin Biochem."},{"key":"B28","first-page":"2S3","article-title":"Biosynthesis and metabolism of carnitine","volume-title":"J Child Neurol.","author":"Lee Carter","year":"1995"},{"key":"B29","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1210\/jc.2014-3157","article-title":"Dietary protein intake affects amino acid and acylcarnitine metabolism in infants aged 6 months","volume":"100","author":"Kirchberg","year":"2015","journal-title":"J Clin Endocrinol Metab."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1089\/thy.2017.0218","article-title":"Treatment of swedish patients with graves' hyperthyroidism is associated with changes in acylcarnitine levels","volume":"27","author":"Mahmoud","year":"2017","journal-title":"Thyroid."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1089\/thy.2000.10.1043","article-title":"Carnitine is a naturally occurring inhibitor of thyroid hormone nuclear uptake","volume":"10","author":"Benvenga","year":"2000","journal-title":"Thyroid."},{"key":"B32","doi-asserted-by":"publisher","first-page":"3579","DOI":"10.1210\/jcem.86.8.7747","article-title":"Usefulness of L-carnitine, a naturally occurring peripheral antagonist of thyroid hormone action, in iatrogenic hyperthyroidism: a randomized, double-blind, placebo-controlled clinical trial","volume":"86","author":"Benvenga","year":"2001","journal-title":"J Clin Endocrinol Metab."},{"key":"B33","first-page":"2268","article-title":"A novel treatment for subclinical hyperthyroidism: a pilot study on the beneficial effects of l-carnitine and selenium","volume":"21","author":"Nordio","year":"2017","journal-title":"Eur Rev Med Pharmacol Sci."},{"key":"B34","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/sj.ejcn.1601150","article-title":"The mediterranean score of dietary habits in Chinese populations in four different geographical areas","volume":"55","author":"Woo","year":"2001","journal-title":"Eur J Clin Nutr."},{"key":"B35","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1093\/ajcn.81.2.341","article-title":"Origins and evolution of the Western diet: health implications for the 21st century","volume":"81","author":"Cordain","year":"2005","journal-title":"Am J Clin Nutr."},{"key":"B36","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.clinbiochem.2012.10.006","article-title":"Acylcarnitine profile in thyroid disease","volume":"46","author":"Wong","year":"2013","journal-title":"Clin Biochem."},{"key":"B37","doi-asserted-by":"publisher","first-page":"7633","DOI":"10.1038\/ncomms8633","article-title":"Genetic determinants of antithyroid drug-induced agranulocytosis by human leukocyte antigen genotyping and genome-wide association study","volume":"6","author":"Chen","year":"2015","journal-title":"Nat Commun."},{"key":"B38","first-page":"D913","article-title":"Allele frequency net: a database and online repository for immune gene frequencies in worldwide populations","volume-title":"Nucleic Acids Res.","author":"Gonzalez-Galarza","year":"2011"},{"key":"B39","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S2213-8587(16)00113-3","article-title":"Genetic variants associated with antithyroid drug-induced agranulocytosis: a genome-wide association study in a European population","volume":"4","author":"Hallberg","year":"2016","journal-title":"Lancet Diabetes Endocrinol."},{"key":"B40","first-page":"214","article-title":"Methimazole induced total myeloid aplasia with delayed recovery despite granulocyte colony stimulating factor (G-CSF): marrow progenitor recovery kinetics","volume-title":"Ind J Hematol Blood Transf.","author":"Sarker","year":"2016"},{"key":"B41","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1111\/j.1365-2141.1991.tb08042.x","article-title":"Drug-induced agranulocytosis: prognostic factors in a series of 168 episodes","volume":"79","author":"Julia","year":"1991","journal-title":"Br J Haematol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1055\/s-0042-105281","article-title":"Monocyte and basophil counts as predictors of neutrophil count recovery in patients with thiamazole-induced agranulocytosis","volume":"125","author":"Onose","year":"2017","journal-title":"Exp Clin Endocrinol Diab."}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2019.00789\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T04:53:19Z","timestamp":1574398399000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2019.00789\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,22]]},"references-count":42,"alternative-id":["10.3389\/fendo.2019.00789"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2019.00789","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,22]]},"article-number":"789"}}